The DSM-5-TR® Diagnosis Handbook is a medical reference app for clinicians and students, providing interactive decision trees for psychiatric diagnosis on iOS.
Product velocity
Intense
Daily rank 🇺🇸
#99
Medical · grossing
Sentiment
4.6
2k reviews
Nemesis
Merck Manual Professional
The App DNA
What makes this app unique?
Clinicians hire this tool to navigate complex diagnostic paths at the point of care, replacing manual textbook lookup with a faster, algorithmic workflow.
For Clinicians, psychiatrists, and medical students requiring point-of-care diagnostic support for psychiatric conditions.
What does it look like?
Key features
Step-by-step diagnostic flow using yes or no questions to narrow down psychiatric conditions
Reference tables provided after initial diagnosis to confirm or suggest alternative conditions
Feature allowing users to audit their selected decision tree path
How much does it cost?
Freemium model utilizes in-app purchase gates to unlock full clinical content, anchored by the authority of the American Psychiatric Association.
Velocity
Intense developmentShow more...
5 versions in history. Development pace: intense.
Who built it?
Unbound Medicine
13+ apps tracked · Medical
User Sentiment
What do users think recently?
Recent user voice shows a frustrated sentiment. Users appreciate decision tree navigation provides a helpful alternative to manual textbook searching for clinicians.
How are ratings & reviews evolving?
What users say, by theme
- Decision tree navigation provides a helpful alternative to manual textbook searching for clinicians
- Lack of comprehensive diagnostic criteria makes the app feel incomplete for professional use
48 of 48 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for DSM-5-TR® Diagnosis Handbook
How's the Medical market?
The app maintains a presence in the Medical category, with recent activity in the US and international markets (e.g., #90 Grossing in US Category 6020). The gap between its specialized utility and the broader reference tools like Merck Manual limits its grossing potential.
Read the market outlookThe rivals identified
By Merck & Co Inc
This is the primary clinical reference competitor that directly overlaps with the DSM-5-TR's target audience of medical professionals seeking authoritative, diagnostic-focused content.
- Provides comprehensive clinical content across all medical specialties rather than focusing solely on psychiatric diagnostic criteria.
- Leverages the trusted Merck brand authority to maintain high user trust among clinicians and medical students.
- Offers a broader clinical scope that serves as a daily utility for general practitioners and specialists.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for DSM-5-TR® Diagnosis Handbook
Where is it heading?
The clinical reference market is consolidating around tools that provide comprehensive, evidence-based synthesis. The app remains in a stable but vulnerable position, as its specialized psychiatric focus is currently undermined by authentication friction and content gaps that drive users toward broader generalist competitors.
- Persistent complaints regarding incomplete diagnostic criteria suggest the current content depth is insufficient for professional clinical reliance.
- The latest update targeting purchase reliability addresses a long-standing complaint cluster, which should stabilize the recent negative review trend.
The SWOT
- Interactive decision trees replace manual textbook lookups for rapid point-of-care diagnostic flow
- Expansion of decision trees into personality disorders
- Integration of official billing codes for clinical documentation
Next best moves
Audit post-purchase authentication flow because user complaints flag payment loops as a top friction point → reduce refund surge
+ 1 more prioritized moveThe counter-intuitive read
The app's perceived incompleteness is a feature, not a bug…
Read the full takeFeature gaps
Comprehensive clinical content across all medical specialties (available in Merck Manual Professional but missing here) +1
Since the last report: The app transitioned to a freemium model and introduced new diagnostic audit features, but faces significant user friction regarding authentication and content depth.
Bottom line
The app provides high-utility diagnostic decision trees, but the perception of being an incomplete reference tool and friction in the purchase flow limit its professional adoption, so the PM should prioritize authentication stability and content depth to reduce churn.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated